Pasar al contenido principal

Impacto funcional de los mecanismos de regulación epigenética en envejecimiento y cáncer

IJC2018-036825-I

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal de Promoción del Talento y su Empleabilidad en I+D+i
Subprograma Subprograma Estatal de Incorporación
Convocatoria Juan de la Cierva Incorporación
Año convocatoria 2018
Plan Estatal 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 3
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Physical exercise shapes the mouse brain epigenome

  • Urdinguio, Rocío G.
  • Tejedor, Juan Ramón
  • Fernández-Sanjurjo, Manuel
  • Pérez, Raúl F.
  • Peñarroya, Alfonso
  • Ferrero, Cecilia
  • Codina-Martínez, Helena
  • Díez-Planelles, Carlos
  • Pinto-Hernández, Paola
  • Castilla-Silgado, Juan
  • Coto-Vilcapoma, Almudena
  • Díez-Robles, Sergio
  • Blanco-Agudín, Noelia
  • Tomás-Zapico, Cristina
  • Iglesias-Gutiérrez, Eduardo
  • Fernández-García, Benjamín
  • Fernández, Agustín F.
  • Fraga, Mario F.
[Objective]: To analyze the genome-wide epigenomic and transcriptomic changes induced by long term resistance or endurance training in the hippocampus of wild-type mice., [Methods]: We performed whole-genome bisulfite sequencing (WGBS) and RNA sequencing (RNA-seq) of mice hippocampus after 4 weeks of specific training. In addition, we used a novel object recognition test before and after the intervention to determine whether the exercise led to an improvement in cognitive function., [Results]: Although the majority of DNA methylation changes identified in this study were training-model specific, most were associated with hypomethylation and were enriched in similar histone marks, chromatin states, and transcription factor biding sites. It is worth highlighting the significant association found between the loss of DNA methylation in Tet1 binding sites and gene expression changes, indicating the importance of these epigenomic changes in transcriptional regulation. However, endurance and resistance training activate different gene pathways, those being associated with neuroplasticity in the case of endurance exercise, and interferon response pathways in the case of resistance exercise, which also appears to be associated with improved learning and memory functions., [Conclusions]: Our results help both understand the molecular mechanisms by which different exercise models exert beneficial effects for brain health and provide new potential therapeutic targets for future research., This work was supported by the Spanish Association Against Cancer (PROYE18061FERN to M.F.F.), the Asturias Government (PCTI) co-funding 2018-2022/FEDER (IDI/2018/146 to M.F.F.), the Fundación General CSIC (0348_CIE_6_E to M.F.F.), the Health Institute Carlos III (Plan Nacional de I+D+I) co-funding FEDER (PI18/01527 to M.F.F and A.F.F.), the MINECO (DEP2015-69980-P to B.F.G.), and the Fundación Tatiana Pérez de Guzmán el Bueno (“Ayudas a Proyectos de Investigación en Neurociencia-2020” to C.T.Z and E.I.G.). R.G.U. is supported by the Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER). J.R.T. is supported by a Juan de la Cierva fellowship from the Spanish Ministry of Science and Innovation MCIN/AEI /10.13039/501100011033 (IJC2018-036825-I). R.F.P. is supported by the Severo Ochoa program (BP17-114). P.P.H. is supported by Ayudas para la realización de Tesis Doctorales. Modalidad A fellowship from the University of Oviedo (PAPI-20-PF-19). We also acknowledge support from the IUOPA-ISPA-FINBA (the IUOPA is supported by the Obra Social Cajastur-Liberbank, Spain)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Nicotinamide N-methyltransferase (NNMT) regulates the glucocorticoid signaling pathway during the early phase of adipogenesis

  • Roberti, Annalisa
  • Tejedor, Juan Ramón
  • Díaz-Moreno, Irene
  • López, Virginia
  • Santamarina-Ojeda, Pablo
  • Pérez, Raúl F.
  • Urdinguio, Rocío G.
  • Concellón, Carmen
  • Martínez-Chantar, María Luz
  • Fernández-Morera, Juan L.
  • Díaz-Quintana, Antonio
  • Amo, Vicente del
  • Fernández, Agustín F.
  • Fraga, Mario F.
Obesity is associated with adipose tissue dysfunction through the differentiation and expansion of pre-adipocytes to adipocytes (hyperplasia) and/or increases in size of pre-existing adipocytes (hypertrophy). A cascade of transcriptional events coordinates the differentiation of pre-adipocytes into fully differentiated adipocytes; the process of adipogenesis. Although nicotinamide N-methyltransferase (NNMT) has been associated with obesity, how NNMT is regulated during adipogenesis, and the underlying regulatory mechanisms, remain undefined. In present study we used genetic and pharmacological approaches to elucidate the molecular signals driving NNMT activation and its role during adipogenesis. Firstly, we demonstrated that during the early phase of adipocyte differentiation NNMT is transactivated by CCAAT/Enhancer Binding Protein beta (CEBPB) in response to glucocorticoid (GC) induction. We found that Nnmt knockout, using CRISPR/Cas9 approach, impaired terminal adipogenesis by influencing the timing of cellular commitment and cell cycle exit during mitotic clonal expansion, as demonstrated by cell cycle analysis and RNA sequencing experiments. Biochemical and computational methods showed that a novel small molecule, called CC-410, stably binds to and highly specifically inhibits NNMT. CC-410 was, therefore, used to modulate protein activity during pre-adipocyte differentiation stages, demonstrating that, in line with the genetic approach, chemical inhibition of NNMT at the early stages of adipogenesis impairs terminal differentiation by deregulating the GC network. These congruent results conclusively demonstrate that NNMT is a key component of the GC-CEBP axis during the early stages of adipogenesis and could be a potential therapeutic target for both early-onset obesity and glucocorticoid-induced obesity., This work was supported by the Spanish Association Against Cancer (PROYE18061FERN to M.F.F.), the Asturias Government (PCTI) co-funding 2018-2023/FEDER (IDI/2018/146 and IDI/2021/000077 to M.F.F.), the Health Institute Carlos III (Plan Nacional de I+D+I) co-funding FEDER (PI18/01527 and PI21/01067 to M.F.F and A.F.F.), CIBERER Acciones Cooperativas y Complementarias Intramurales (ACCI20-35 to M.F.F.), the Fundación General CSIC (0348_CIE_6_E to M.F.F.), the ISCIII (COV00624 to J.R.T. and M.F.F.), ISPA and the Asociación Galbán (2021-052-INTRAMUR GALBAN-GOURR to R.G.U.), ISPA-Jannsen (2021-048-INTRAMURAL NOV-TEVAR to J.R.T.), CSIC (202020E092 to M.F.F), and the European Commission NextGenerationEU, through CSIC’s Global Health Platform (PTI Salud Global) and the Spanish Ministry of Science and Innovation through the Recovery, Transformation and Resilience Plan (SGL2021-03-39 and SGL2021-03-040). The authors are also grateful to the Spanish Ministry of Science and Innovation (PID2021-126663NB-100; CTQ2016-76829-R; PID2020-113473GB-I00), the Regional Government of Andalusia (BIO198 and P18-FR-3487) and the Ramón Areces Foundation (2021-2024). A.R. is supported by CSIC (SOLAUT_00038505 SGL2103040). J.R.T. is supported by a Juan de la Cierva fellowship from the Spanish Ministry of Science and Innovation MCIN/AEI/https://doi.org/10.13039/501100011033 (IJC2018-036825-I). R.F.P. (BP17-114) and P.S.M. (BP17-165) are supported by the Severo Ochoa program. R.G.U. is supported by the Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER). M.L.M.-C is supported by grants from Ministerio de Ciencia, Innovación y Universidades (MICINN) PID2020-117116RB-I00 integrated in Plan Estatal de Investigación Científica y Técnica y Innovación (to M.L.M.-C), and co-funded with Fondos FEDER (to M.L.M.-C), Subprograma Retos Colaboración RTC2019-007125-1 (to M.L.M.-C), La Caixa Foundation Program HR17-00601 (to MLM-C), Proyectos Investigación en Salud DTS20/00138 (to M.L.M.-C), Departamento de Industria del Gobierno Vasco (to M.L.M.-C), Elkartek (KK-2020/00008) (to M.L.M.-C). We also acknowledge support from the Institute of Oncology of Asturias (IUOPA, supported by Obra Social Cajastur Liberbank, Spain), the Health Research Institute of Asturias (ISPA-FINBA) and Consorcio Centro de Investigación Biomédica en Red (CIBERER-ISCIII)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

CRISPR/dCAS9-mediated DNA demethylation screen identifies functional epigenetic determinants of colorectal cancer

  • Tejedor, Juan Ramón
  • Peñarroya, Alfonso
  • Gancedo-Verdejo, Javier
  • Santamarina-Ojeda, Pablo
  • Pérez, Raúl F.
  • López-Tamargo, Sara
  • Díez-Borge, Ana
  • Alba-Linares, Juan J.
  • González-Del-Rey, Nerea
  • Urdinguio, Rocío G.
  • Mangas, Cristina
  • Roberti, Annalisa
  • López, Virginia
  • Morales-Ruiz, Teresa
  • Ariza, Rafael R.
  • Roldán-Arjona, Teresa
  • Meijón, Mónica
  • Valledor, Luis
  • Cañal, María Jesús
  • Fernández-Martínez, Daniel
  • Fernández-Hevia, María
  • Jiménez-Fonseca, Paula
  • García-Flórez, Luis J.
  • Fernández, Agustín F.
  • Fraga, Mario F.
[Background]: Promoter hypermethylation of tumour suppressor genes is frequently observed during the malignant transformation of colorectal cancer (CRC). However, whether this epigenetic mechanism is functional in cancer or is a mere consequence of the carcinogenic process remains to be elucidated., [Results]: In this work, we performed an integrative multi-omic approach to identify gene candidates with strong correlations between DNA methylation and gene expression in human CRC samples and a set of 8 colon cancer cell lines. As a proof of concept, we combined recent CRISPR-Cas9 epigenome editing tools (dCas9-TET1, dCas9-TET-IM) with a customized arrayed gRNA library to modulate the DNA methylation status of 56 promoters previously linked with strong epigenetic repression in CRC, and we monitored the potential functional consequences of this DNA methylation loss by means of a high-content cell proliferation screen. Overall, the epigenetic modulation of most of these DNA methylated regions had a mild impact on the reactivation of gene expression and on the viability of cancer cells. Interestingly, we found that epigenetic reactivation of RSPO2 in the tumour context was associated with a significant impairment in cell proliferation in p53-/- cancer cell lines, and further validation with human samples demonstrated that the epigenetic silencing of RSPO2 is a mid-late event in the adenoma to carcinoma sequence., [Conclusions]: These results highlight the potential role of DNA methylation as a driver mechanism of CRC and paves the way for the identification of novel therapeutic windows based on the epigenetic reactivation of certain tumour suppressor genes., This work was supported by Health Institute Carlos III (Plan Nacional de I + D + I) co-funding FEDER (PI18/01527 and PI21/01067 to M.F.F. and A.F.F.; COV00624 to J.R.T. and M.F.F.), the Spanish Association Against Cancer (PROYE18061FERN to M.F.F.), the Asturias Government (PCTI) co-funding 2018-2023/FEDER (IDI/2018/146 and IDI/2021/000077 to M.F.F.), The Junta de Andalucía co-funding FEDER (PY20_00051 to T.R.-A.), ISPA-Jannsen (2021-048-INTRAMURAL NOV-TEVAR to J.R.T.) and the European Commission NextGenerationEU, through CSIC’s Global Health Platform (PTI Salud Global) and the Spanish Ministry of Science and Innovation through the Recovery, Transformation and Resilience Plan (SGL2021-03-39 and SGL2021-03-040). J.R.T. is supported by the Spanish Ministry of Science and Innovation (IJC2018-036825-I and RYC2021-031799-I). A.P. is supported by the ISCIII (FI19/00085). J.G.V. is supported by the Spanish Ministry of Universities (FPU20/04659). R.F.P. (BP17-114) and P.S.M. (BP17-165) are supported by the Severo Ochoa program. R.G.U. is supported by the Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER). J.J.A.L. is supported by the AECC fellowship (PRDAS21642ALBA). A.R. is supported by CSIC (SOLAUT_00038505 SGL2103040)., Peer reviewed